Article
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
JAMA oncology - 1 Dec 2017
Goode Ellen L, Block Matthew S, Kalli Kimberly R, Vierkant Robert A, Chen Wenqian, Fogarty Zachary C, Gentry-Maharaj Aleksandra, Tołoczko Aleksandra, Hein Alexander, Bouligny Aliecia L, Jensen Allan, Osorio Ana, Hartkopf Andreas, Ryan Andy, Chudecka-Głaz Anita, Magliocco Anthony M, Hartmann Arndt, Jung Audrey Y, Gao Bo, Hernandez Brenda Y, Fridley Brooke L, McCauley Bryan M, Kennedy Catherine J, Wang Chen, Karpinskyj Chloe, de Sousa Christiani B, Tiezzi Daniel G, Wachter David L, Herpel Esther, Taran Florin Andrei, Modugno Francesmary, Nelson Gregg, Lubiński Jan, Menkiszak Janusz, Alsop Jennifer, Lester Jenny, García-Donas Jesús, Nation Jill, Hung Jillian, Palacios José, Rothstein Joseph H, Kelley Joseph L, de Andrade Jurandyr M, Robles-Díaz Luis, Intermaggio Maria P, Widschwendter Martin, Beckmann Matthias W, Ruebner Matthias, Jimenez-Linan Mercedes, Singh Naveena, Oszurek Oleg, Harnett Paul R, Rambau Peter F, Sinn Peter, Wagner Philipp, Ghatage Prafull, Sharma Raghwa, Edwards Robert P, Ness Roberta B, Orsulic Sandra, Brucker Sara Y, Johnatty Sharon E, Longacre Teri A, Ursula Eilber, McGuire Valerie, Sieh Weiva, Natanzon Yanina, Li Zheng, Whittemore Alice S, Anna deFazio, Staebler Annette, Karlan Beth Y, Gilks Blake, Bowtell David D, Høgdall Estrid, Candido dos Reis Francisco J, Steed Helen, Campbell Ian G, Gronwald Jacek, Benítez Javier, Koziak Jennifer M, Chang-Claude Jenny, Moysich Kirsten B, Kelemen Linda E, Cook Linda S, Goodman Marc T, García María José, Fasching Peter A, Kommoss Stefan, Deen Suha, Kjaer Susanne K, Menon Usha, Brenton James D, Pharoah Paul DP, Chenevix-Trench Georgia, Huntsman David G, Winham Stacey J, Köbel Martin, Ramus Susan J
Abstract excerpt
Importance: Cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8+ TILs by histotype and in relation to other clinical factors. Objective: To define the prognostic role of CD8+ TILs in epithelial ovarian cancer. Design, Setting, and Participants: This was a multicenter observational, prospective...
